Alerts will be sent to your verified email
Verify Email
ZENITHDRUG
|
Zenith Drugs
|
Curis Lifesciences
|
Source Natural Foods
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
19.81 % | 63.11 % | 15.02 % |
|
5yr average Equity Multiplier
|
3.92 | 1.91 | 1.3 |
|
5yr Average Asset Turnover Ratio
|
1.08 | 1.07 | 1.2 |
|
5yr Avg Net Profit Margin
|
5.08 % | 8.37 % | 9.68 % |
|
Price to Book
|
1.21 | 5.18 | 3.84 |
|
P/E
|
11.73 | 13.79 | 30.39 |
|
5yr Avg Cash Conversion Cycle
|
-5.9 Days | 45.79 Days | 76.73 Days |
|
Inventory Days
|
59.46 Days | 77.61 Days | 41.67 Days |
|
Days Receivable
|
153.74 Days | 65.45 Days | 71.97 Days |
|
Days Payable
|
283.33 Days | 245.93 Days | 43.97 Days |
|
5yr Average Interest Coverage Ratio
|
3.87 | 5.43 | 17.98 |
|
5yr Avg ROCE
|
26.61 % | 36.41 % | 22.38 % |
|
5yr Avg Operating Profit Margin
|
9.63 % | 16.92 % | 16.15 % |
|
5 yr average Debt to Equity
|
1.03 | 0.12 | 0.09 |
|
5yr CAGR Net Profit
|
17.92 % | 65.64 % | -2.96 % |
|
5yr Average Return on Assets
|
5.28 % | 9.21 % | 11.87 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
69.98 % | n/a | 74.37 % |
|
Share Pledged by Promoters
|
0.0 | n/a | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | n/a | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | n/a | 0.0 |
|
Zenith Drugs
|
Curis Lifesciences
|
Source Natural Foods
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
-
|
|
Distribution Channel
|
Distribution Channel
|
-
|
-
|